Exceptional Use Recommendation for Nuclear Emergency Drug

The EMA has given a positive opinion for the exceptional circumstances authorization of Imreplys (sargramostim) to treat myelosuppression after acute radiation exposure. Medscape Medical News

Read the full article on medscape.com